The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Open accessAbstract
As part of a World Health Organization-led effort to update the empirical evidence base for the leishmaniases, national experts provided leishmaniasis case data for the last 5 years and information regarding treatment and control in their respective countries and a comprehensive literature review was conducted covering publications on leishmaniasis in 98 countries and three territories (see 'Leishmaniasis Country Profiles Text S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11, S12, S13, S14, S15, S16, S17, S18, S19, S20, S21, S22, S23, S24, S25, S26, S27, S28, S29, S30, S31, S32, S33, S34, S35, S36, S37, S38, S39, S40, S41, S42, S43, S44, S45, S46, S47, S48, S49, S50, S51, S52, S53, S54, S55, S56, S57, S58, S59, S60, S61, S62, S63, S64, S65, S66, S67, S68, S69, S70, S71, S72, S73, S74, S75, S76, S77, S78, S79, S80, S81, S82, S83, S84, S85, S86, S87, S88, S89, S90, S91, S92, S93, S94, S95, S96, S97, S98, S99, S100, S101'). Additional information was collated during meetings conducted at WHO regional level between 2007 and 2011. Two questionnaires regarding epidemiology and drug access were completed by experts and national program managers. Visceral and cutaneous leishmaniasis incidence ranges were estimated by country and epidemiological region based on reported incidence, underreporting rates if available, and the judgment of national and international experts. Based on these estimates, approximately 0.2 to 0.4 cases and 0.7 to 1.2 million VL and CL cases, respectively, occur each year. More than 90% of global VL cases occur in six countries: India, Bangladesh, Sudan, South Sudan, Ethiopia and Brazil. Cutaneous leishmaniasis is more widely distributed, with about one-third of cases occurring in each of three epidemiological regions, the Americas, the Mediterranean basin, and western Asia from the Middle East to Central Asia. The ten countries with the highest estimated case counts, Afghanistan, Algeria, Colombia, Brazil, Iran, Syria, Ethiopia, North Sudan, Costa Rica and Peru, together account for 70 to 75% of global estimated CL incidence. Mortality data were extremely sparse and generally represent hospital-based deaths only. Using an overall case-fatality rate of 10%, we reach a tentative estimate of 20,000 to 40,000 leishmaniasis deaths per year. Although the information is very poor in a number of countries, this is the first in-depth exercise to better estimate the real impact of leishmaniasis. These data should help to define control strategies and reinforce leishmaniasis advocacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mucocutaneous and visceral disease can be lethal if untreated, but most deaths are attributable to visceral leishmaniasis (103).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Depending on the species, Leishmania can cause self-healing cutaneous lesions (e.g., L. tropica, L. major, L. mexicana, and L. pifanoi), disfiguring mucocutaneous disease (e.g., L. braziliensis and L. guyanensis), or severe visceral illness (e.g., L. donovani and L. Infantum chagasi).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [103]
Experimental — accuracy not yet measuredIn the citing paper
“we must consider the important zoonotic potential of the diseases studied, as the presence of human infections or risk of infection has already been described (5, 24, 25, 28).”
From Current Distribution of Selected Vector-Borne Diseases in Dogs in Spain (2020) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · Cited by 6,884
Disease control priorities in developing countries
(2006) · Choice Reviews Online · doi:10.5860/choice.44-0343 · Cited by 3,636
Leishmaniasis: current situation and new perspectives
Desjeux, P. M. P. (2004) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2004.03.004 · Cited by 2,329 · cited 1×
“Reported leishmaniasis case figures are widely acknowledged to represent gross underestimates of the true burden, but studies that measure the degree of underreporting are rare [23].”
BackgroundBank, W. (1993) · doi:10.1596/0-1952-0890-0 · Cited by 2,213
King, C. H., Dickman, K. R., & Tisch, D. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66457-4 · Cited by 898 · cited 1×
“The accuracy of this measure depends on the reliability of the incidence, duration, severity and mortality data for a given condition, as well as the underlying assumptions used in the calculations [7,14].”
BackgroundHealth metrics and evaluation: strengthening the science
Murray, C. J., & Frenk, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60526-7 · Cited by 849
Hotez, P. J., Molyneux, D. H., Fenwick, A., Ottesen, E. A., Sachs, S. E., & Sachs, J. D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030102 · Cited by 822 · cited 1×
“Although estimated to cause the ninth largest disease burden among individual infectious diseases, leishmaniasis is largely ignored in discussions of tropical disease priorities [1,2].”
BackgroundAlvar, J., Yactayo, S., & Bern, C. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.09.004 · Cited by 813 · cited 1×
“This consignment to critical oblivion results from its complex epidemiology and ecology, the lack of simple, easily-applied tools for case management and the paucity of current incidence data, and often results in a failure on the part of policy-makers to recognize its importance [3,4].”
BackgroundDesjeux, P. M. P. (1996) · Clinics in Dermatology · doi:10.1016/0738-081x(96)00057-0 · Cited by 588 · cited 1×
“Visceral leishmaniasis (VL) results in death if not treated, the majority of leishmaniasis deaths go unrecognized, and even with treatment access, VL may result in case-fatality rates of 10–20% [17,18,19,20,21,22].”
BackgroundLibrary, W. (2010) · Cited by 584
Flagged first, then by citations
Research works printed but not linked: 1
- AN Maia-Elkhoury, 2007, [Analysis of visceral leishmaniasis reports by the capture-recapture method]., Rev Saude Publica, 41, 931
Cited by
Sorted by citations
Items 301–400 of 1,004
Leishmaniasis: treatment, drug resistance and emerging therapies
Sundar, S., Chakravarty, J., & Meena, L. P. (2018) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2019.1552853 · Cited by 77
Caridha, D. P., Vesely, B. A., Bocxlaer, K. V., Arana, B. A., Mowbray, C. E., Rafati, S., Uliana, S. R. B., Reguera, R. M., Kreishman-Deitrick, M., Sciotti, R. J., et al. (2019) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2019.06.003 · Cited by 77
Chaubey, P., Patel, R. R., & Mishra, B. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.917076 · Cited by 77
A New ABC Half-Transporter in Leishmania major Is Involved in Resistance to Antimony
Manzano, J. I., García‐Hernández, R., Castanys, S., & Gamarro, F. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00211-13 · Cited by 77
Telomeric gene deletion and intrachromosomal amplification in antimony‐resistant L eishmania
Mukherjee, A., Boisvert, S., do Monte‐Neto, R. L., Coelho, A. C., Raymond, F., Mukhopadhyay, R., Corbeil, J., & Ouellette, M. (2013) · Molecular Microbiology · doi:10.1111/mmi.12178 · Cited by 77
Canine-Based Strategies for Prevention and Control of Visceral Leishmaniasis in Brazil
Sevá, A. D. P., Galvis‐Ovallos, F., Amaku, M., Carrillo, E., Moreno, J., Galati, E. A. B., Lopes, E. G., Soares, R. M., & Ferreira, F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160058 · Cited by 77
Synthesis and leishmanicidal activity of eugenol derivatives bearing 1,2,3-triazole functionalities
Teixeira, R. R., Gazolla, P. A. R., da Silva, A. M., Borsodi, M. P. G., Rossi‐Bergmann, B., Ferreira, R. S., Vaz, B. G., Vasconcelos, G. A., & Lima, W. P. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.046 · Cited by 77
Boggild, A. K., Caumes, É., Grobusch, M. P., Schwartz, E., Hynes, N. A., Libman, M., Connor, B. A., Chakrabarti, S., Parola, P., Keystone, J. S., et al. (2019) · Journal of Travel Medicine · doi:10.1093/jtm/taz055 · Cited by 77
Alkylphospholipids: An update on molecular mechanisms and clinical relevance
Ríos‐Marco, P., Marco, C., Gálvez, X., Jiménez‐López, J. M., & Carrasco, M. P. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.02.016 · Cited by 78
Raja, Z., André, S., Abbassi, F., Humblot, V., Lequin, O., Bouceba, T., Correia, I., Casale, S., Foulon, T., Séréno, D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174024 · Cited by 76
Endoplasmic Reticulum Stress and Unfolded Protein Response in Infection By Intracellular Parasites
Galluzzi, L., Diotallevi, A., & Magnani, M. (2017) · Future Science OA · doi:10.4155/fsoa-2017-0020 · Cited by 76
Romero, G. A. S., Costa, D. L., Costa, C. H. N., de Almeida, R. P., de Melo, E. V., de Carvalho, S. F. G., Rabello, A., de Carvalho, A. L., Sousa, A. D. Q., Leite, R. D., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005706 · Cited by 76
Faria, A. R., Veloso, L. D. C., Coura‐Vital, W., Reis, A. B., Damasceno, L. M., Gazzinelli, R. T., & de Andrade, H. M. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003429 · Cited by 76
The Cell Biology of Leishmania: How to Teach Using Animations
Teixeira, D., Benchimol, M., Rodrigues, J. C. F., Crepaldi, P. H., Pimenta, P. F. P., & de Souza, W. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003594 · Cited by 76
Risk factors of visceral leishmaniasis: a case control study in north-western Ethiopia
Yared, S., Deribe, K., Gebreselassie, A., Lemma, W., Akililu, E., Kirstein, O. D., Balkew, M., Warburg, A., Gebre-Michael, T., & Hailu, A. (2014) · Parasites & Vectors · doi:10.1186/preaccept-7749314101347455 · Cited by 76
Brianti, E., Gaglio, G., Napoli, E., Falsone, L., Prudente, C., Basano, F. S., Latrofa, M. S., Tarallo, V. D., Dantas‐Torres, F., Capelli, G., et al. (2014) · Parasites & Vectors · doi:10.1186/1756-3305-7-327 · Cited by 76
Antileishmanial Activity of a Series of N 2, N 4-Disubstituted Quinazoline-2,4-diamines
Horn, K. S. V., Zhu, X., Pandharkar, T., Yang, S., Vesely, B. A., Vanaerschot, M., Dujardin, J., Rijal, S., Kyle, D. E., Wang, M. Z., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5000408 · Cited by 76
Dong, G., Filho, A. L., & Olivier, M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00100 · Cited by 79
Prevention of feline leishmaniosis with an imidacloprid 10%/flumethrin 4.5% polymer matrix collar
Brianti, E., Falsone, L., Napoli, E., Gaglio, G., Giannetto, S., Pennisi, M. G., Priolo, V., Latrofa, M. S., Tarallo, V. D., Basano, F. S., et al. (2017) · Parasites & Vectors · doi:10.1186/s13071-017-2258-6 · Cited by 75
Phylogenomic Reconstruction Supports Supercontinent Origins for Leishmania
Harkins, K. M., Schwartz, R. S., Cartwright, R. A., & Stone, A. C. (2015) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2015.11.030 · Cited by 75
Gow, I., Smith, N. C., Stark, D. J., & Ellis, J. (2022) · Parasites & Vectors · doi:10.1186/s13071-022-05524-z · Cited by 92
Aulner, N., Danckaert, A., Rouault, E., Desrivot, J., Helynck, O., Commère, P., Munier‐Lehmann, H., Späth, G. F., Shorte, S. L., Milon, G., et al. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002154 · Cited by 75
Herrador, Z., Gherasim, A., Jimenez, B. C., Granados, M., Martín, J. V. S., & Aparicio, P. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003594 · Cited by 75
Regina-Silva, S., Feres, A. M. L. T., França-Silva, J. C., Dias, E. S., Michalsky, É. M., de Andrade, H. M., Coelho, E. A. F., Ribeiro, G. M., Fernandes, A. P., & Machado-Coelho, G. L. L. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.03.019 · Cited by 75
Zhang, W., Lypaczewski, P., & Matlashewski, G. (2017) · mSphere · doi:10.1128/msphere.00340-16 · Cited by 77
Hirve, S. S., Kroeger, A., Matlashewski, G., Mondal, D., Banjara, M. R., Das, P. K., Be-Nazir, A., Arana, B. A., & Olliaro, P. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005889 · Cited by 75
Rastrojo, A., García‐Hernández, R., Vargas, P., Camacho, E., Corvo, L., Imamura, H., Dujardin, J., Castanys, S., Aguado, B., Gamarro, F., et al. (2018) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2018.04.002 · Cited by 75
Isenring, E., Fehr, J. S., Gültekin, N., & Schlagenhauf, P. (2018) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2018.04.014 · Cited by 74
Domagalska, M. A., Imamura, H., Sanders, M. J., den Broeck, F. V., Bhattarai, N. R., Vanaerschot, M., Maes, I., D’haenens, E., Rai, K., Rijal, S., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007900 · Cited by 67
Canuto, G. A. B., Castilho-Martins, E. A., Tavares, M. F. M., Rivas, L., Barbas, C., & López‐Gonzálvez, Á. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-7772-1 · Cited by 74
Cogo, J., Kaplum, V., Sangi, D. P., Ueda‐Nakamura, T., Corrêa, A. G., & Nakamura, C. V. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.11.018 · Cited by 74
Cutaneous Leishmaniasis and Sand Fly Fluctuations Are Associated with El Niño in Panamá
Chaves, L. F., Calzada, J. E., Valderrama, A., & Saldaña, A. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003210 · Cited by 74
Soares, D. C., Portella, N. A., Ramos, M. F. D. S., Siani, A. C., & Saraiva, E. M. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/761323 · Cited by 74
Das, A., Jawed, J. J., Das, M. C., Sandhu, P., De, U. C., Dinda, B., Akhter, Y., & Bhattacharjee, S. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.04.022 · Cited by 78
Cutaneous leishmaniasis in Iran: A systematic review and meta-analysis
Sabzevari, S., Teshnizi, S. H., Shokri, A., Bahrami, F., & Kouhestani, F. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104721 · Cited by 73
DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis
Mowbray, C. E., Braillard, S., Glossop, P. A., Whitlock, G. A., Jacobs, R. T., Speake, J. D., Pandi, B., Nare, B., Maes, L. J. R. M., Yardley, V., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01437 · Cited by 73
Medley, G. F., Hollingsworth, T. D., Olliaro, P., & Adams, E. R. (2015) · Nature · doi:10.1038/nature16042 · Cited by 73
Pandey, R. K., Kumbhar, B. V., Srivastava, S., Malik, R., Sundar, S., Kunwar, A., & Prajapati, V. K. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2015.1135298 · Cited by 73
Khan, N. H., Bari, A. U., Hashim, R., Khan, I., Muneer, A., Shah, A. S., Wahid, S., Yardley, V., O'Neil, B., & Sutherland, C. J. (2016) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0343 · Cited by 73
Leishmaniavirus-Dependent Metastatic Leishmaniasis Is Prevented by Blocking IL-17A
Hartley, M., Bourreau, E., Rossi, M., Castiglioni, P., Eren, R. O., Prével, F., Couppié, P., Hickerson, S. M., Launois, P., Beverley, S. M., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005852 · Cited by 78
Patiño, L. H., Méndez, C., Rodríguez, O., Romero, Y., Velandia, D., Alvarado, M., Pérez, J., Duque, M. C., & Ramírez, J. D. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005876 · Cited by 73
Souto, D. E. P., Volpe, J., Gonçalves, C. D. C., Ramos, C. H. I., & Kubota, L. T. (2019) · Talanta · doi:10.1016/j.talanta.2019.120122 · Cited by 73
Baranwal, A., Chiranjivi, A. K., Kumar, A., Dubey, V. K., & Chandra, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-27170-1 · Cited by 72
López, L., Vélez, I. D., Asela, C., Cruz, C., Alves, F. P., Robledo, S. M., & Arana, B. A. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006653 · Cited by 72
Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight
Jamshaid, H., Din, F. U., & Khan, G. M. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00853-0 · Cited by 76
Nzelu, C. O., Cáceres, A. G., Arrunátegui-Jiménez, M. J., Lañas-Rosas, M. F., Yañez-Trujillano, H. H., Luna-Caipo, D. V., Mauricci, C. H., Katakura, K., Hashiguchi, Y., & Kato, H. (2015) · Acta Tropica · doi:10.1016/j.actatropica.2015.02.003 · Cited by 72
Modular Multiantigen T Cell Epitope–Enriched DNA Vaccine Against Human Leishmaniasis
Das, S., Freier, A., Boussoffara, T., Das, S., Oswald, D., Losch, F., Selka, M., Sacerdoti‐Sierra, N., Schönian, G., Wiesmüller, K., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008222 · Cited by 72
Sharifi, I., Aflatoonian, M. R., Fekri, A., Parizi, M. H., Afshar, A. A., Khosravi, A., Sharifi, F., Aflatoonian, B., Khamesipour, A., Dowlati, Y., et al. (2015) · PubMed Central · Cited by 72
Detection and molecular identification of leishmania RNA virus (LRV) in Iranian Leishmania species
Hajjaran, H., Mahdi, M., Mohebali, M., Samimi‐Rad, K., Ataei‐Pirkooh, A., Kazemirad, E., Naddaf, S. R., & Raoofian, R. (2016) · Archives of Virology · doi:10.1007/s00705-016-3044-z · Cited by 72
Evaluation of the impacts of climate change on disease vectors through ecological niche modelling
de Carvalho, B. M., Rangel, E. F., & Vale, M. M. (2016) · Bulletin of Entomological Research · doi:10.1017/s0007485316001097 · Cited by 76
Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis
Galvão, E. L., Rabello, A., & Cota, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186117 · Cited by 72
In Vitro and In Vivo Effectiveness of Carvacrol, Thymol and Linalool against Leishmania infantum
Youssefi, M. R., Moghaddas, E., Tabari, M. A., Moghadamnia, A. A., Hosseini, S. M., Farash, B. R. H., Ebrahimi, M. A., Mousavi, N. N., Fata, A., Maggi, F., et al. (2019) · Molecules · doi:10.3390/molecules24112072 · Cited by 72
The enemy within: Targeting host–parasite interaction for antileishmanial drug discovery
Lamotte, S., Späth, G. F., Rachidi, N., & Prina, E. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005480 · Cited by 71
Lima-Junior, D. S., Mineo, T. W. P., Calich, V. L. G., & Zamboni, D. S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700258 · Cited by 71
Kumar, R., Bunn, P. T., Singh, S. S., Ng, S. S., de, M. M., Rivera, F. D. L., Chauhan, S. B., Singh, N., Faleiro, R. J., Edwards, C. L., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.099 · Cited by 73
Shaw, C. D., Lonchamp, J., Downing, T., Imamura, H., Freeman, T. M., Cotton, J. A., Sanders, M. J., Blackburn, G. J., Dujardin, J., Rijal, S., et al. (2015) · Molecular Microbiology · doi:10.1111/mmi.13291 · Cited by 70
Enterocin AS-48 as Evidence for the Use of Bacteriocins as New Leishmanicidal Agents
Abengózar, M. Á., Cebrián, R., Saugar, J. M., Gárate, T., Valdivia, E., Martínez‐Bueno, M., Maqueda, M., & Rivas, L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02288-16 · Cited by 71
Clemente, W. T., Pierrotti, L. C., Abdala, E., Morris, M. I., Azevedo, L. S., López‐Vélez, R., Cuenca‐Estrella, M., Torre‐Cisneros, J., Petersen, E., Camargo, L. F. A., et al. (2018) · Transplantation · doi:10.1097/tp.0000000000002027 · Cited by 71
Leishmania Spp-Host Interaction: There Is Always an Onset, but Is There an End?
Conceição‐Silva, F., & Morgado, F. N. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00330 · Cited by 71
Soares, I. R., Silva, S. O., Moreira, F. M., Prado, L. G., Fantini, P., Maranhão, R. D. P. A., Filho, J. M. D. S., Melo, M. N., & Palhares, M. S. (2013) · Veterinary Parasitology · doi:10.1016/j.vetpar.2013.06.014 · Cited by 70
Mondal, D., Alvar, J., Hasnain, M. G., Hossain, M. S., Ghosh, D., Huda, M. M., Nabi, S. G., Sundar, S., Matlashewski, G., & Arana, B. A. (2013) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70118-9 · Cited by 70
Chaves, J. D. S., Tunes, L. G., Franco, C. H. J., Francisco, T. M., Corrêa, C. C., Murta, S. M. F., do Monte‐Neto, R. L., Silva, H., Fontes, A. P. S., & de Almeida, M. V. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.10.052 · Cited by 71
Leishmaniasis in Sri Lanka: spatial distribution and seasonal variations from 2009 to 2016
Galgamuwa, L. S., Dharmaratne, S. D., & Iddawela, D. (2018) · Parasites & Vectors · doi:10.1186/s13071-018-2647-5 · Cited by 70
Post kala-azar dermal leishmaniasis: A threat to elimination program
Gedda, M. R., Singh, B., Kumar, D., Singh, A. K., Madhukar, P., Upadhyay, S., Singh, O. P., & Sundar, S. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008221 · Cited by 70
Dantas‐Torres, F., Tarallo, V. D., & Otranto, D. (2014) · Parasites & Vectors · doi:10.1186/preaccept-1213561303136450 · Cited by 70
Bhandari, V., Sundar, S., Dujardin, J., & Salotra, P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01574-13 · Cited by 70
Tsegaw, T., Gadisa, E., Seid, A., Abera, A., Teshome, A., Mulugeta, A., Herrero, M., Argaw, D., Jorge, A., & Aseffa, A. (2013) · Geospatial health · doi:10.4081/gh.2013.88 · Cited by 70
Zampieri, R. A., Laranjeira‐Silva, M. F., Muxel, S. M., de Lima, A. C. S., Shaw, J. J., & Floeter‐Winter, L. M. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004485 · Cited by 70
Kalangi, S. K., Dayakar, A., Gangappa, D., Sathyavathi, R., Maurya, R., & Rao, D. N. (2016) · Experimental Parasitology · doi:10.1016/j.exppara.2016.09.002 · Cited by 70
Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites
Badirzadeh, A., Taheri, T., Taslimi, Y., Abdossamadi, Z., Heidari‐Kharaji, M., Gholami, E., Sedaghat, B., Niyyati, M., & Rafati, S. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005774 · Cited by 70
León, C. M., Muñoz, M., Hernández, C., Ayala, M. S., Flórez, C., Teherán, A. A., Cubides, J. R., & Ramírez, J. D. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01907 · Cited by 70
Chemical control and insecticide resistance status of sand fly vectors worldwide
Balaska, S., Fotakis, E. A., Chaskopoulou, A., & VONTAS, J. G. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009586 · Cited by 70
Coelho, A. C., Trinconi, C. T., Costa, C. H. N., & Uliana, S. R. B. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002999 · Cited by 69
Kar, N., Chakraborty, S., De, A. K., Ghosh, S., & Bera, T. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.03.046 · Cited by 72
von Zuben, A. P. B., & Donalísio, M. R. (2016) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00087415 · Cited by 68
Dikhit, M. R., Kumar, A., Das, S., Dehury, B., Rout, A. K., Jamal, F., Sahoo, G. C., Topno, R. K., Pandey, K., Das, V. N. R., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01763 · Cited by 68
Younis, B. M., Osman, M., Khalil, E. A. G., Santoro, F., Furini, S., Wiggins, R. C., Keding, A., Carraro, M., Musa, A. E. A., Abdarahaman, M. A. A., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.03.020 · Cited by 68
Vulnerabilities to and the Socioeconomic and Psychosocial Impacts of the Leishmaniases: A Review
Grifferty, G., Shirley, H., McGloin, J. M., Kahn, J., Orriols, A. M., & Wamai, R. G. (2021) · Research and Reports in Tropical Medicine · doi:10.2147/rrtm.s278138 · Cited by 72
Coelho, E. A. F., Ribeiro, T. G., Fuscaldi, L. L., Santos, M., Duarte, M., Lage, P. S., Martins, V. T., Costa, L. E., Diniz, S., Cardoso, V. N., et al. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s68966 · Cited by 68
Pujol, A., Naveros, B. C., Calpena, A. C., Pastor, P. H., Fisa, R., & Lizandra, C. R. (2015) · Nanomedicine · doi:10.2217/nnm.14.102 · Cited by 68
Coura‐Vital, W., de Araújo, V. E. M., Reis, I. A., Amâncio, F. F., Reis, A. B., & Carneiro, M. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003374 · Cited by 68
Vivero, R. J., Gutierrez, C. T., Bejarano, E. E., Peña, H. C., Estrada, L. G., Florez, F., Ortega, E., Aparicio, Y., & Muskus, C. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-0711-y · Cited by 68
Heidari‐Kharaji, M., Taheri, T., Doroud, D., Habibzadeh, S., Badirzadeh, A., & Rafati, S. (2016) · Parasite Immunology · doi:10.1111/pim.12340 · Cited by 68
Guimarães, L. H., Queiroz, A., Silva, J., Silva, S. C., Magalhães, V., Lago, E., Machado, P. R. L., Bacellar, O., Wilson, M. E., Beverley, S. M., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005100 · Cited by 68
Culling Dogs for Zoonotic Visceral Leishmaniasis Control: The Wind of Change
Dantas‐Torres, F., Miró, G., Bowman, D. D., Gradoni, L., & Otranto, D. (2018) · Trends in Parasitology · doi:10.1016/j.pt.2018.11.005 · Cited by 67
Baidouri, F. E., Diancourt, L., Berry, V., Chevenet, F., Pratlong, F., Marty, P., & Ravel, C. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002255 · Cited by 67
Fonseca-Silva, F., Canto‐Cavalheiro, M. M., Menna‐Barreto, R. F. S., & de Almeida-Amaral, E. E. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00011 · Cited by 67
Activity of anti-cancer protein kinase inhibitors against Leishmania spp.
Sanderson, L., Yardley, V., & Croft, S. L. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku069 · Cited by 67
A newly emerged cutaneous leishmaniasis focus in central Iran
Rostami, M. N., Saghafipour, A., & Vesali, E. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.07.003 · Cited by 67
Bhattacharya, P., Ghosh, S., Ejazi, S. A., Rahaman, M., Pandey, K., Das, V. N. R., Das, P. K., Goswami, R. P., Saha, B., & Ali, N. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004422 · Cited by 67
Coimbra, E. S., Antinarelli, L. M. R., Silva, N. P., Souza, I. D. O., Meinel, R. S., Rocha, M. N., Soares, R. P., & da Silva, A. D. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.10.017 · Cited by 67
Cuddihy, G., Wasan, E. K., Di, Y., & Wasan, K. M. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030099 · Cited by 69
Dantas‐Torres, F., Sales, K. G. D. S., da Silva, L. G., Otranto, D., & Figueredo, L. A. (2016) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2016.08.006 · Cited by 66
Miró, G., & López‐Vélez, R. (2018) · Veterinary Parasitology · doi:10.1016/j.vetpar.2018.03.002 · Cited by 68
Ramesh, V., Kaushal, H., Mishra, A. K., Singh, R., & Salotra, P. (2015) · BMC Public Health · doi:10.1186/s12889-015-2424-8 · Cited by 66
Vector and reservoir control for preventing leishmaniasis
González, U., Pinart, M., Sinclair, D., Firooz, A., Enk, C. D., Vélez, I. D., Esterhuizen, T. M., Tristan, M. G., & Alvar, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008736.pub2 · Cited by 68
Burza, S., Sinha, P. K., Mahajan, R., Lima, M. A., Mitra, G., Verma, N., Balasegarem, M., & Das, P. K. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002603 · Cited by 66
Burza, S., Sinha, P. K., Mahajan, R., Lima, M. A., Mitra, G., Verma, N., Balsegaram, M., & Das, P. K. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002536 · Cited by 66
Gradoni, L. (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.30.20539 · Cited by 66
The Global Pandemic of Falsified Medicines: Laboratory and Field Innovations and Policy Perspectives
Nayyar, G. M. L., Breman, J. G., & Herrington, J. E. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0221 · Cited by 66
Metadata
- Authors
- Alvar, J., Vélez, I. D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., Boer, M. D., & the WHO Leishmaniasis Control Team
- Affiliations
- World Health Organization (CH)
- Universidad de Antioquia (CO)
- Centers for Disease Control and Prevention (US)
- Instituto de Salud Carlos III (ES)
- Corresponding author
- Alvar, Jorge
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-05-31
- Volume
- 7
- Issue
- 5
- Pages
- e35671
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3365071
- OpenAlex
- W2107915297
- Cited by
- 5,141
- References
- 51
- Citations by year
- 2026: 177 · 2025: 229 · 2024: 257 · 2023: 305 · 2022: 358 · 2021: 456 · 2020: 468 · 2019: 458 · 2018: 515 · 2017: 440 · 2016: 465 · 2015: 361 · 2014: 404 · 2013: 200 · 2012: 38
- FWCI
- 310.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Sanofi
- Universidad de Medellín
- Pan American Health Organization
- Agencia Española de Cooperación Internacional para el Desarrollo
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Research on Leishmaniasis Studies
- Health Sciences › Medicine › Infectious Diseases › Leprosy Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › Brucella: diagnosis, epidemiology, treatment
- Keywords
- leishmaniasis, visceral leishmaniasis, cutaneous leishmaniasis, leishmaniasis incidence, country profile, leishmaniasis control, leishmaniasis treatment, access to medicines, neglected tropical diseases, case data
- MeSH terms
- Female, Geography, Humans, Leishmaniasis, Male, Time Factors, World Health Organization, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
